Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263806 · ClinicalTrials.gov registry record · NA
The Computed Tomography-derived Fractional Flow Reserve STAT Trial
A NA study, sponsored by Corewell Health East.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03263806 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 13 participants.
The verdict
NCT03263806, a NA study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study is designed to directly compare Standard Care and CT fractional flow reserve (CTFFR) for diagnosis of chest pain patients with definite coronary artery disease (CAD) on heart computed tomography (CT) scans.
Interventions
- DIAGNOSTIC_TEST CTFFR-Guided Group Management
- DIAGNOSTIC_TEST SOC Group Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2017-08-24 |
| Est. Completion | 2018-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03263806
The ClinicalTrials.gov registry entry for NCT03263806 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CTFFR-Guided Group Management is the first listed.
NCT03263806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03263806 about?
NCT03263806 is a clinical study titled "The Computed Tomography-derived Fractional Flow Reserve STAT Trial". This study is designed to directly compare Standard Care and CT fractional flow reserve (CTFFR) for diagnosis of chest pain patients with definite coronary artery disease (CAD) on heart computed tomography (CT) scans.
What is the current status of trial NCT03263806?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2017-08-24. Estimated completion is 2018-04-04.
What interventions are being tested in trial NCT03263806?
The interventions under investigation include: CTFFR-Guided Group Management (DIAGNOSTIC_TEST), SOC Group Management (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03263806?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.